How We Verify Pharmacists

The MentionFox Pharmacist Vetting Report is a research synthesis built from public-record sources. It is NOT a license-of-record verification, NOT a clinical-competence assessment, NOT a substitute for a state pharmacy board lookup of record, and NOT a substitute for due diligence through your Credentialing Verification Organization. Read this page in full before relying on the report for a credentialing, hiring, or care decision.

Pharmacists are NPI-covered (CMS taxonomy 183500000X) but are NOT covered by the federal Sunshine Act / Open Payments program — that database tracks payments to physicians, dentists, podiatrists, optometrists, chiropractors, and APRNs/PAs only. Reports for pharmacists therefore differ structurally from physician reports: there is no Open Payments section. Instead, when the subject is a compounding pharmacist, we surface their FDA 503A/503B inspection record — a vetter-unique data source not used by any other report.

Who reads these reports

Four use cases drive the report's framing:

• Self-verification — pharmacists assembling credentialing packets for PBM panels (CVS Caremark, Express Scripts, OptumRx), hospital pharmacy committees, multi-state license renewals (NABP e-License + MPJE/CPJE), specialty board cert applications (BPS), Medicaid/Medicare provider enrollment, and consultant pharmacist credentialing for long-term care. The cover page reframes to Verification & Disclosure Summary.
• Hospital pharmacy committee credentialing — health systems credentialing clinical pharmacists, pharmacy directors, and consultant pharmacists annually as part of the medical staff review.
• Pharmacy chain hiring — CVS, Walgreens, Walmart, Costco, Kroger pharmacy chains hiring at scale. Light background checks miss specialty cert + sanctions patterns; this report supplements.
• Patient research for independent / compounding pharmacies — patients selecting between compounding pharmacies (sterile compounding, hormone replacement therapy, custom dose preparation, veterinary compounding) want assurance the pharmacy has a clean state board record, no FDA compounding violations, and the pharmacist holds appropriate specialty cert.

Subject resolution

Pharmacist resolution is identical to physician resolution: NPI is the canonical identifier, with disambiguation when name + state returns multiple candidates.

1. 10-digit NPI — when provided directly, we go straight to the CMS NPI Registry and pull the verified record.
2. Last name + state + optional first name + optional specialty — when the NPI is unknown, we query the NPI Registry's name index restricted to pharmacist taxonomy (183500000X). The result set is presented as a disambiguation chooser; the requester picks the right candidate before any credit is charged.
3. Disambiguation fallback — when the candidate set is large, additional disambiguators surface (city, sub-specialty, practice setting). We never auto-pick from a multi-candidate result.

Data sources — what we use

What's NOT used (and why)

• DEA registration data — not publicly searchable; lookup requires DEA-issued credentials. The report does not surface DEA registration numbers, DEA status, or controlled-substance prescribing patterns.
• PBM (Pharmacy Benefit Manager) network rosters — proprietary CVS Caremark / Express Scripts / OptumRx data. Out of scope.
• State controlled-substance prescribing data — fragmented, mostly law-enforcement / board-only access. Defamation risk if name match wrong.
• Medicare Part D opioid prescribing patterns — public dataset exists but defamation risk with bad name matches is severe. Deferred to v0.2 with mandatory NPI exact match.
• Anonymous patient complaint forums, subreddit / forum posts naming pharmacists — defamation risk floor.
• State sex-offender / prohibited-persons registries — defamation risk; the state pharmacy board action surface covers when relevant.
• CMS Open Payments (Sunshine Act) — pharmacists are NOT a covered recipient. The Sunshine Act covers physicians, dentists, podiatrists, optometrists, chiropractors, APRNs, and PAs only.
• Healthgrades — returns 404 for pharmacist subjects (verified). Don't waste a Firecrawl call.

Source class hierarchy (ICD 206)

Each cited source falls into one of three classes, weighted differently when the synthesis evaluates evidence strength:

1. Federal-Primary — directly authored by a US federal agency (CMS, NIH, FDA, OIG). Authoritative for the claim it supports.
2. Authoritative-Secondary — state pharmacy boards, BPS specialty certification, ASHP / APhA professional bodies, NABP cross-state license verification, PCAB / IACP for compounding.
3. Aggregator — Yelp, Google reviews. Treated as patient-experience signal, never as quality assessment.

The 12-section Full Vetting Report's References section (Section 12) groups every cited URL by source class so the reader can verify class-by-class.

Confidence ratings (ICD 203)

Where a section asserts a probabilistic claim, it uses the PHIA probability vocabulary (almost no chance / very unlikely / unlikely / roughly even chance / likely / very likely / almost certain). Bands are picked based on data-density. When evidence is thin, the band defaults to "roughly even chance" with an explicit "[insufficient public evidence]" tag.

Defamation guardrails

Pharmacist verification carries elevated legal risk: a false claim that lowers a clinician's professional standing can be defamatory per se. The synthesis follows a strict cite-don't-characterize policy:

• State licensure facts — only what the state pharmacy board's own public record says. No interpretation.
• OIG LEIE matches — quoted exclusion type, date, and reinstatement record verbatim from the federal record.
• FDA compounding inspection findings — quoted from the FDA inspection report directly. Inspection observations (Form 483) are reported as observations, not as adjudicated wrongdoing.
• Patient sentiment — characterized as patient experience, not clinical quality.
• Civil malpractice filings — when surfaced via CourtListener, framed as litigation activity rather than adjudicated wrongdoing.

Section-by-section methodology

1. Executive Summary

Generated last. Pulls verdict-relevant facts from each prior section: NPI status, OIG result, BPS specialty cert, FDA compounding inspection record (when applicable), publications, and any HIGH-severity flags.

2. Identity & Credentials

Verified-identity record from NPI Registry + state pharmacy board licensure status. Credentials (RPh / PharmD), enumeration date, primary taxonomy, sub-specialty taxonomies, license states.

3. Specialty Certification & Practice Profile

BPS Diplomate status across the 14 BPS specialties. ASHP Fellow / residency record. Practice setting (chain / independent / hospital / clinical / compounding / consulting).

4. License & Disciplinary History

The single highest-stakes section. Leads with OIG LEIE result. State pharmacy board lookup URL surfaced for direct verification. NABP cross-state record when available.

5. Publication & Research Record

PubMed total publications, iCite h-index proxy, NIH grants, top-cited works. Most clinical pharmacists publish little — section explicitly notes "Publication record consistent with clinical-practice focus" when total publications are below 20.

6. FDA Compounding & Inspection Record (NEW — vetter-unique)

For pharmacists involved in compounding (503A traditional or 503B outsourcing facility), the FDA's inspection database surfaces inspection dates, Form 483 observations, warning letters, and import alerts. Reported as inspection-record data, never as adjudicated misconduct. For non-compounding pharmacists, the section degrades to "Subject not engaged in FDA-registered compounding; 503A/503B inspection database not applicable."

7. Practice Affiliations & Setting

Practice locations from NPI record cross-referenced with pharmacy practice profile data. PCAB-accredited compounding pharmacies surface here when the subject is affiliated.

8. Comparable Pharmacists

Five archetype-matched peers from the comparable_pharmacists_reference table (~30 seeded entries spanning 8 practice settings). Composite scoring on specialty, practice setting, career stage, and archetype.

9. Public Reputation & Patient Sentiment

Yelp + Google Reviews aggregation for the practice (where applicable). Less narrative than physician reports because most pharmacy reviews are short.

10. Malpractice Surface

CourtListener civil malpractice case search with pharmacy-specific terms. Bounded by strong disclaimers: civil filings are litigation activity, not adjudicated wrongdoing.

11. Network & Professional Connections

PubMed co-authorship graph. ASHP fellow co-listings. BPS specialty cohort connections.

12. References & Source Citations

JS-aggregated audit trail of every URL cited across the prior 11 sections, deduplicated and grouped by source class.

Limitations + what this report is NOT

• NOT a license-of-record verification. Credentialing decisions of record require direct state pharmacy board verification or NABP e-Profile query.
• NOT a clinical-competence assessment.
• NOT pharmaceutical advice or prescribing guidance.
• NOT a substitute for DEA registration verification (which requires DEA-issued credentials).
• NOT a substitute for malpractice case retrieval through qualified medical-legal counsel.
• NOT a guarantee against future misconduct. The report reflects the public record at the date generated.

Verifiability

Every claim in a Pharmacist Vetting Report cites a public URL the reader can verify. Claims without citations do not appear — replaced with the [insufficient public evidence as of {date}] tag. The reports are auditable: a credentialing committee or compliance reviewer can re-run the verification chain by hand from the citations alone.

Related verifications